Herr HW - Search Results

1

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.

Scher HI, Yagoda A, Herr HW, Sternberg CN, Morse MJ, Sogani PC, Watson RC, Reuter V, Whitmore WF Jr, Fair WR. Scher HI, et al. Among authors: herr hw. J Urol. 1988 Mar;139(3):475-7. doi: 10.1016/s0022-5347(17)42496-7. J Urol. 1988. PMID: 3343729

2

Impact of a second transurethral resection on the staging of T1 bladder cancer.

Dalbagni G, Herr HW, Reuter VE. Dalbagni G, et al. Among authors: herr hw. Urology. 2002 Nov;60(5):822-4; discussion 824-5. doi: 10.1016/s0090-4295(02)01920-9. Urology. 2002. PMID: 12429307

3

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.

Konety BR, Eastham JA, Reuter VE, Scardino PT, Donat SM, Dalbagni G, Russo P, Herr HW, Schwartz L, Kantoff PW, Scher H, Kelly WK. Konety BR, et al. Among authors: herr hw. J Urol. 2004 Feb;171(2 Pt 1):709-13. doi: 10.1097/01.ju.0000108122.36893.5a. J Urol. 2004. PMID: 14713792 Clinical Trial.

4

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Pfister DG, Lin SY, Bajorin D, Scher HI, Herr H, Fair W, Morse M, et al. Motzer RJ, et al. Cancer. 1990 Jun 1;65(11):2465-70. doi: 10.1002/1097-0142(19900601)65:11<2465::aid-cncr2820651112>3.0.co;2-7. Cancer. 1990. PMID: 1692505

5

Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Motzer RJ, Geller NL, Tan CC, Herr H, Morse M, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ. Motzer RJ, et al. Cancer. 1991 Mar 1;67(5):1305-10. doi: 10.1002/1097-0142(19910301)67:5<1305::aid-cncr2820670506>3.0.co;2-j. Cancer. 1991. PMID: 1703917 Clinical Trial.

6

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P, et al. Motzer RJ, et al. Cancer. 1990 Dec 15;66(12):2476-81. doi: 10.1002/1097-0142(19901215)66:12<2476::aid-cncr2820661206>3.0.co;2-d. Cancer. 1990. PMID: 2174300 Clinical Trial.

7

M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Darshaw D, Reuter V, et al. Scher H, et al. Prog Clin Biol Res. 1990;353:179-86. Prog Clin Biol Res. 1990. PMID: 2217417 No abstract available.

8

Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.

Fair WR, Scher H, Herr H, Morse M, Sogani P, Bosi G, Dershaw D, Reuter V, Curley T, et al. Fair WR, et al. Semin Urol. 1990 Aug;8(3):190-6. Semin Urol. 1990. PMID: 2399387 No abstract available.

9

Advanced seminoma: the role of chemotherapy and adjunctive surgery.

Motzer RJ, Bosl GJ, Geller NL, Penenberg D, Yagoda A, Golbey R, Whitmore WF Jr, Fair WR, Sogani P, Herr H, et al. Motzer RJ, et al. Ann Intern Med. 1988 Apr;108(4):513-8. doi: 10.7326/0003-4819-108-4-513. Ann Intern Med. 1988. PMID: 2450500

10

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Dershaw D, Reuter V, et al. Scher H, et al. Br J Urol. 1989 Sep;64(3):250-6. doi: 10.1111/j.1464-410x.1989.tb06008.x. Br J Urol. 1989. PMID: 2804561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

600 results

Search Page

Filters